Recently, this potential mechanism was studied specifically for hBD-2, which was able to bind to SARS-CoV-2 RBD and inhibit the binding of this RBD to hACE2, leading to the inhibition of the virus spreading, which pointed out the role of this AMP in fighting against COVID-19 (5). This evidence concerns the gene DEFB4A and COVID-19.